Lv5
1170 积分 2023-11-06 加入
Engineering multi-specific nano-antibodies for cancer immunotherapy
3个月前
已完结
SM03, an Anti-CD22 Antibody, Converts Cis-to-Trans Ligand Binding of CD22 against α2,6-Linked Sialic Acid Glycans and Immunomodulates Systemic Autoimmune Diseases
4个月前
已完结
Glycobiology of cellular expiry: Decrypting the role of glycan-lectin regulatory complex and therapeutic strategies focusing on cancer
7个月前
已完结
Spatial fibroblast niches define Crohn’s fistulae
8个月前
已完结
The TL1A inhibitors in IBD: what’s in the pot?
9个月前
已完结
SDP-LIV1, a Novel and Optimized LIV-1 Antibody-drug Conjugate Demonstrating Superior Anti-Tumor Efficacy and Favorable Safety Profile for Treatment of Solid Tumors
10个月前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
11个月前
已完结
Dual-payload ADCs move into first oncology clinical trials
1年前
已完结
Unlocking the potential of bispecific ADCs for targeted cancer therapy
1年前
已完结
Antibody–drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry
1年前
已完结
皖公网安备34019202002308
